Xanthomonas maltophilia: an emerging nosocomial pathogen.

[1]  H. Mett,et al.  Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. , 1988, Reviews of infectious diseases.

[2]  A. Chow,et al.  Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia , 1988, Antimicrobial Agents and Chemotherapy.

[3]  W. Opferkuch,et al.  Imipenem resistance in Pseudomonas aeruginosa is due to diminished expression of outer membrane proteins. , 1987, The Journal of infectious diseases.

[4]  V. Yu,et al.  Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. , 1987, Archives of internal medicine.

[5]  G. Bodey,et al.  In-vitro susceptibility of Pseudomonas species to fifteen antimicrobial agents. , 1987, The Journal of antimicrobial chemotherapy.

[6]  J. Janda,et al.  Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum , 1986, Journal of clinical microbiology.

[7]  M. Jacobs,et al.  Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads. , 1986, The Journal of antimicrobial chemotherapy.

[8]  R. Wenzel,et al.  Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital , 1986, Journal of clinical microbiology.

[9]  M. Thomassen,et al.  Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. , 1985, Diagnostic microbiology and infectious disease.

[10]  T. Nagai.  Association of Pseudomonas maltophilia with malignant lesions , 1984, Journal of clinical microbiology.

[11]  K. Subbannayya,et al.  Pseudomonas maltophilia endocarditis. , 1984, Indian journal of pathology & microbiology.

[12]  S. Mitsuhashi,et al.  Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873 , 1984, Antimicrobial Agents and Chemotherapy.

[13]  J. Jorgensen,et al.  Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli , 1983, Antimicrobial Agents and Chemotherapy.

[14]  D. Graham,et al.  DNA hybridization studies of the association of Pseudomonas maltophilia with inflammatory bowel diseases. , 1983, The Journal of laboratory and clinical medicine.

[15]  P. Vos,et al.  Transfer of Pseudomonas maltophilia Hugh 1981 to the Genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. , 1983 .

[16]  V. Yu,et al.  Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. , 1982, Reviews of infectious diseases.

[17]  S. Mitsuhashi,et al.  Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia , 1982, Antimicrobial Agents and Chemotherapy.

[18]  G. Davis,et al.  Enzymatic profile of Pseudomonas maltophilia , 1982, Journal of clinical microbiology.

[19]  D. Trump,et al.  CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy. , 1982, Archives of internal medicine.

[20]  M. Fisher,et al.  Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. , 1981, JAMA.

[21]  V. Yu,et al.  Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. , 1980, The Journal of infectious diseases.

[22]  V. Yu,et al.  Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination , 1979, Antimicrobial Agents and Chemotherapy.

[23]  T. Sarkar,et al.  Primary Pseudomonas maltophilia infection of the lung. , 1979, Postgraduate medicine.

[24]  S. Lapage,et al.  Distribution in clinical material and identification of Pseudomonas maltophilia. , 1979, Journal of clinical pathology.

[25]  V. Yu,et al.  Pseudomonas maltophilia causing heroin-associated infective endocarditis. , 1978, Archives of internal medicine.

[26]  P. Mitchell,et al.  Cell wall-defective variants of pseudomonas-like (group Va) bacteria in Crohn's disease. , 1978, Gastroenterology.

[27]  R. Moellering,et al.  Patterns and mechanisms of antibiotic resistance. , 1978, The Medical clinics of North America.

[28]  J. D. Semel,et al.  Pseudomonas maltophilia pseudosepticemia. , 1978, The American journal of medicine.

[29]  L. A. Hatch,et al.  Pseudomonas maltophilia bacteremia associated with a prolapsed mitral valve. , 1977, American journal of clinical pathology.

[30]  T. Riley,et al.  INFECTION WITH PSEUDOMONAS MALTOPHILIA HOSPITAL OUTBREAK DUE TO CONTAMINATED DISINFECTANT , 1976, The Medical journal of Australia.

[31]  D. Harris,et al.  Meningitis caused by Pseudomonas maltophilia. , 1975, Journal of clinical pathology.

[32]  J. Fischer.  Pseudomonas maltophilia endocarditis after replacement of the mitral valve: a case study. , 1973, The Journal of infectious diseases.

[33]  W. Austen,et al.  Prosthetic Valve Endocarditis: Analysis of 38 Cases , 1973, Circulation.

[34]  G. Gilardi.  Infrequently encountered Pseudomonas species causing infection in humans. , 1972, Annals of internal medicine.

[35]  M. Finland.  Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. , 1972, Annals of internal medicine.

[36]  H. D. Harlowe.  Acute mastoiditis following pseudomonas maltophilia infection: Case report , 1972, The Laryngoscope.

[37]  A. Sonnenwirth.  BACTEREMIA WITH AND WITHOUT MENINGITIS DUE TO YERSINIA ENTEROCOLITICA, EDWARDS1ELLA TARDA, COMAMONAS TERRIGENA, AND PSEUDOMONAS MALTOPHILIA , 1970, Annals of the New York Academy of Sciences.

[38]  M. J. Pickett,et al.  Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. , 1970, American journal of clinical pathology.

[39]  M. Swartz,et al.  Nonfermentative gram-negative bacilli of nosocomial interest. , 1970, The American journal of medicine.

[40]  V. Sutter.  Identification of Pseudomonas species isolated from hospital environment and human sources. , 1968, Applied microbiology.

[41]  A. Pitt.  External electrical current in the treatment of ventricular tachycardia. , 1962, The Medical journal of Australia.

[42]  R. Hugh,et al.  Pseudomonas maltophilia, an alcaligenes-like species. , 1961, Journal of general microbiology.

[43]  M. Finland.  Treatment of pneumonia and other serious infections. , 1960, The New England journal of medicine.

[44]  I. Phillips,et al.  Comparative activity of the 4-quinolones. , 1988, Reviews of infectious diseases.

[45]  W. Traub,et al.  Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia. , 1987, Chemotherapy.

[46]  才野 佑之.  Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia , 1985 .

[47]  G. Gilardi.  Pseudomonas maltophilia infections in man. , 1969, American journal of clinical pathology.

[48]  W. Stern,et al.  Bacterial endocarditis following open-heart surgery. , 1967, The Annals of thoracic surgery.